Zuranolone

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 160 publications

Updated guidelines for pharmacologic treatment of perinatal depression: Understanding medication options.

Updated guidelines for pharmacologic treatment of perinatal depression: Understanding medication options.

Journal: Cleveland Clinic journal of medicine

Published: April 01, 2026

ACOG Clinical Practice Update, Zuranolone and Brexanolone for the Treatment of Postpartum Depression: Correction.

ACOG Clinical Practice Update, Zuranolone and Brexanolone for the Treatment of Postpartum Depression: Correction.

Journal: Obstetrics and gynecology

Published: March 19, 2026

Examining New Mothers' Access to Zuranolone.

Examining New Mothers' Access to Zuranolone.

Journal: Ochsner journal

Published: March 19, 2026

▼Zuranolone for the treatment of moderate or severe postnatal depression.

▼Zuranolone for the treatment of moderate or severe postnatal depression.

Journal: Drug and therapeutics bulletin

Published: March 04, 2026

Addressing the Global Mental Health Crisis: How a Human Rights Approach Can Help End the Search for Pharmaceutical Magic Bullets.

Addressing the Global Mental Health Crisis: How a Human Rights Approach Can Help End the Search for Pharmaceutical Magic Bullets.

Journal: Health and human rights

Published: January 15, 2026

Current treatment options for perinatal depression.

Current treatment options for perinatal depression.

Journal: Current opinion in obstetrics & gynecology

Published: January 14, 2026

Zuranolone as a Novel Therapy for Postpartum Depression: A Narrative Review of Current Evidence and Future Directions.

Zuranolone as a Novel Therapy for Postpartum Depression: A Narrative Review of Current Evidence and Future Directions.

Journal: Cureus

Published: January 07, 2026

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: December 15, 2025

Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation.

Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation.

Journal: International journal of molecular sciences

Published: December 01, 2025

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Journal: Drugs

Published: November 26, 2025

Durability of zuranolone in postpartum depression versus major depressive disorder.

Durability of zuranolone in postpartum depression versus major depressive disorder.

Journal: Psychiatry and clinical neurosciences

Published: November 26, 2025

Pregnanolone-Based Prodrugs as a Strategy for Neuroprotective Drug-Like Compounds: Pregnanolone Pyroglutamate and Its Age‑dependent Anticonvulsant Effects in the 6-hz Seizure Model in Immature Rats.

Pregnanolone-Based Prodrugs as a Strategy for Neuroprotective Drug-Like Compounds: Pregnanolone Pyroglutamate and Its Age‑dependent Anticonvulsant Effects in the 6-hz Seizure Model in Immature Rats.

Journal: Drug design, development and therapy

Published: November 12, 2025

Showing 1-12 of 160

Last Updated: 04/28/2026